Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00000813664 · Dead
| Application Number | UK00000813664 |
| Status | Dead |
| Owner | Pfizer Products Inc. |
| Filed | 1960-11-22 |
| Registered | 1960-11-22 |
| Renewal Due | 2005-11-22 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
EQUIVERT has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical substances for use in the treatment of vertigo.
'EQUIVERT' is a dead trademark on the UK IPO register, owned by Pfizer Products Inc.. The application (UK00000813664) was filed on 22 November 1960 and registered on 22 November 1960. The registration is set to expire on 22 November 2005.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Gill Jennings & Every LLP.
According to the UK IPO register, 'EQUIVERT' is owned by Pfizer Products Inc..
No — the UK IPO records the status of 'EQUIVERT' as dead.
'EQUIVERT' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical substances for use in the treatment of vertigo.
The application for 'EQUIVERT' was filed on 22 November 1960 and the trademark was registered on 22 November 1960.
The UK IPO first published / advertised 'EQUIVERT' on 6 December 1961.
The current registration of 'EQUIVERT' is recorded as valid until 22 November 2005, at which point it will need to be renewed to remain in force.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.